Thermo Fisher Scientific Inc., US8835561023

Thermo Fisher Scientific stock sits 1.07 percent below its 52-week high

Published on 10/16/2026 at 15:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Thermo Fisher Scientific stock costs EUR 619.20 on October 16, 2026. Guggenheim kept a USD 740.00 target for the company on October 15, 2026.

Trading range and valuation

  • On October 16, 2026, the NYSE quote stood 1.07 percent below Thermo Fisher Scientific's 52-week high.
  • Thermo Fisher Scientific will release third-quarter results on October 21, 2026.
  • Thermo Fisher Scientific stock costs EUR 619.20 at Lang & Schwarz on October 16, 2026 at 3:32 p.m. CEST.
  • Thermo Fisher Scientific had a market capitalization of USD 256.9 billion on October 16, 2026.
Makroaufnahme illustriert Thermo Fisher Sci. US8835561023 mit Detailansicht beschlagener Laborfläschchen und blauer Flüssigkeit im Fokus, Illustration mit AI erstellt.

Thermo Fisher Scientific stock stood 1.07 percent below its NYSE 52-week high of USD 704.00 on October 16, 2026, with the U.S. quote at USD 696.49. The stock's euro indication was EUR 619.20 at Lang & Schwarz at 3:32 p.m. CEST.

Guggenheim keeps its target

Guggenheim reiterated its Buy rating and maintained a USD 740.00 price target on October 15, 2026, according to Investing.com. Against the USD 696.49 U.S. quote, the target was 6.25 percent higher, using the same currency.

October 21 results date

Thermo Fisher Scientific is scheduled to release its third-quarter 2026 results before the U.S. market opens on October 21, 2026. The company also scheduled a conference call for 7:00 a.m. ET that day, as stated in its investor-relations release.

Stock sits near yearly high

The NYSE quote was last at USD 696.49 at 9:37 a.m. EDT on October 16, 2026. Its 52-week range was USD 435.27 to USD 704.00, while the year-to-date gain was 20.20 percent as of October 15, 2026. The latest quote therefore sat 1.07 percent below the upper end of that range.

Valuation reaches USD 256.9 billion

Thermo Fisher Scientific had a market capitalization of USD 256.9 billion and a trailing P/E ratio of 37.45 on October 16, 2026. The company operates across life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.

Comparison with peers

Thermo Fisher Scientific Inc. (NYSE, USD): minus 0.25 percent, P/E 37.45, market capitalization USD 256.9 billion

Danaher Corporation (NYSE, USD): minus 0.56 percent, P/E 40.96, market capitalization USD 161.9 billion

Illumina, Inc. (Nasdaq, USD): plus 0.38 percent, P/E 50.75, market capitalization USD 40.6 billion

Trading position and next date

For investors, the central near-term marker is the October 21 results date, while the stock is positioned close to its 52-week high. Guggenheim's USD 740.00 target provides a separate valuation reference, but it does not replace the upcoming earnings report as the next scheduled company date.

The euro price was EUR 619.20 at Lang & Schwarz on October 16, 2026 at 3:32 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.

Thermo Fisher Scientific market data

  • Company: Thermo Fisher Scientific Inc.
  • ISIN: US8835561023
  • Ticker: TMO
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 16, 2026, 3:32 p.m. CEST): EUR 619.20
  • Market capitalization: USD 256.9 billion (as of October 16, 2026)
  • 52-week range: USD 435.27-704.00 (as of October 16, 2026)
  • Sector / Industry: Healthcare / Diagnostics and Research
  • Next earnings date: October 21, 2026

Market context: Market report S&P 500.

More news and analyses on Thermo Fisher Scientific stock

Disclaimer...
en | US8835561023 | THERMO FISHER SCIENTIFIC INC. | boerse | 70340799 | bgmi